For CD99, 81% of non-EwS tumor samples were classified consistently across all three cores per sample, for BCL11B 97.6%, and for GLG1 and 94.8% (Figure 3), indicating only little intra-tumoral heterogeneity in EwS differential diagnoses. This evidence concerns the gene BCL11B and neoplasm.